New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
It's taking longer to schedule abortions in the US. Doctors fear riskier, more complex procedures

It's taking longer to schedule abortions in the US. Doctors fear riskier, more complex procedures

by Laura UngarJillaine St.Michel stands for a portrait in Boise, Idaho on Saturday, Dec. 2, 2023. A year earlier, she learned that her previous 20-week fetus had multiple genetic and developmental pro
OB & GYN January 13,2024
It's taking longer to schedule abortions in the US. Doctors fear riskier, more complex procedures

It's taking longer to schedule abortions in the US. Doctors fear riskier, more complex procedures

by Laura UngarJillaine St.Michel stands for a portrait in Boise, Idaho on Saturday, Dec. 2, 2023. A year earlier, she learned that her previous 20-week fetus had multiple genetic and developmental pro
OB & GYN January 13,2024
Good maternal health 'reparations' has lifelong benefits for women, research finds

Good maternal health 'reparations' has lifelong benefits for women, research finds

byUniversity of BirminghamMaternal health production process. The diagram illustrates the relationships and interdependencies of superdeterminants, showing how the characteristics of the planet
OB & GYN January 13,2024
Good maternal health 'reparations' has lifelong benefits for women, research finds

Good maternal health 'reparations' has lifelong benefits for women, research finds

byUniversity of BirminghamMaternal health production process. The diagram illustrates the relationships and interdependencies of superdeterminants, showing how the characteristics of the planet
OB & GYN January 13,2024
Neoadjuvant nivolumab shows long-term benefit in patients with non–small cell lung cancer

Neoadjuvant nivolumab shows long-term benefit in patients with non–small cell lung cancer

byAmerican Association for Cancer ResearchA–D, Kaplan–Meier curves depicting the recurrence-free survival (A) and overall survival (B) for patients who underwent definitive resection after recei
Oncology January 13,2024
Neoadjuvant nivolumab shows long-term benefit in patients with non–small cell lung cancer

Neoadjuvant nivolumab shows long-term benefit in patients with non–small cell lung cancer

byAmerican Association for Cancer ResearchA–D, Kaplan–Meier curves depicting the recurrence-free survival (A) and overall survival (B) for patients who underwent definitive resection after recei
Oncology January 13,2024
Thrush: Zinc may prevent yeast infections—new research

Thrush: Zinc may prevent yeast infections—new research

by Rebecca A. Drummond,The ConversationCandida albicans. Credit: Wikipedia.Around a half-billion women experience a vaginal yeast infection (thrush) every year—with around 140 million women suff
OB & GYN January 13,2024
Thrush: Zinc may prevent yeast infections—new research

Thrush: Zinc may prevent yeast infections—new research

by Rebecca A. Drummond,The ConversationCandida albicans. Credit: Wikipedia.Around a half-billion women experience a vaginal yeast infection (thrush) every year—with around 140 million women suff
OB & GYN January 13,2024
CDC: Admission rate to ICU 1.8 per 1,000 live births for mothers

CDC: Admission rate to ICU 1.8 per 1,000 live births for mothers

by Elana GotkineFor mothers delivering live-born infants in 2020 to 2022, the admission rate to an intensive care unit (ICU) was 1.8 per 1,000 live births, according to a December data brief published
OB & GYN January 13,2024
CDC: Admission rate to ICU 1.8 per 1,000 live births for mothers

CDC: Admission rate to ICU 1.8 per 1,000 live births for mothers

by Elana GotkineFor mothers delivering live-born infants in 2020 to 2022, the admission rate to an intensive care unit (ICU) was 1.8 per 1,000 live births, according to a December data brief published
OB & GYN January 13,2024
A common abortion pill will come before the US Supreme Court. Here's how mifepristone works

A common abortion pill will come before the US Supreme Court. Here's how mifepristone works

by Matthew PerroneBottles of abortion pills mifepristone, left, and misoprostol, right, at a clinic in Des Moines, Iowa, on Sept. 22, 2010. Medication abortion is the preferred method of ending pregna
OB & GYN January 13,2024
A common abortion pill will come before the US Supreme Court. Here's how mifepristone works

A common abortion pill will come before the US Supreme Court. Here's how mifepristone works

by Matthew PerroneBottles of abortion pills mifepristone, left, and misoprostol, right, at a clinic in Des Moines, Iowa, on Sept. 22, 2010. Medication abortion is the preferred method of ending pregna
OB & GYN January 13,2024
Metformin added to insulin not beneficial for T2D in pregnancy

Metformin added to insulin not beneficial for T2D in pregnancy

by Elana GotkineFor pregnant women with type 2 diabetes, the addition of metformin to insulin does not affect composite adverse neonatal outcomes, according to a study published in the Dec. 12 issue o
OB & GYN January 13,2024
Metformin added to insulin not beneficial for T2D in pregnancy

Metformin added to insulin not beneficial for T2D in pregnancy

by Elana GotkineFor pregnant women with type 2 diabetes, the addition of metformin to insulin does not affect composite adverse neonatal outcomes, according to a study published in the Dec. 12 issue o
OB & GYN January 13,2024
Maternal mortality rate is much higher for Black women than white women in Mississippi, study says

Maternal mortality rate is much higher for Black women than white women in Mississippi, study says

by Emily Wagster PettusDr. Michelle Owens, a maternal fetal medicine subspecialist, speaks on Feb. 22, 2023 at the state Capitol in Jackson, Miss. Owens is one of the leaders of a committee that publi
OB & GYN January 13,2024
Maternal mortality rate is much higher for Black women than white women in Mississippi, study says

Maternal mortality rate is much higher for Black women than white women in Mississippi, study says

by Emily Wagster PettusDr. Michelle Owens, a maternal fetal medicine subspecialist, speaks on Feb. 22, 2023 at the state Capitol in Jackson, Miss. Owens is one of the leaders of a committee that publi
OB & GYN January 13,2024
Newly identified personalized immunotherapy combination treats an aggressive form of advanced prostate cancer

Newly identified personalized immunotherapy combination treats an aggressive form of advanced prostate cancer

byUniversity of Chicago Medical CenterCredit: Unsplash/CC0 Public DomainImmunotherapies have been successful in treating many cancer conditions; however, not much success has yet been achieved i
Oncology January 13,2024
Newly identified personalized immunotherapy combination treats an aggressive form of advanced prostate cancer

Newly identified personalized immunotherapy combination treats an aggressive form of advanced prostate cancer

byUniversity of Chicago Medical CenterCredit: Unsplash/CC0 Public DomainImmunotherapies have been successful in treating many cancer conditions; however, not much success has yet been achieved i
Oncology January 13,2024
State abortion access key factor in future US doctors' training (residency) choices, finds study

State abortion access key factor in future US doctors' training (residency) choices, finds study

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainState access to abortion is a key factor in choosing where to apply for residency (training) programs for around three out of four futur
OB & GYN January 13,2024
State abortion access key factor in future US doctors' training (residency) choices, finds study

State abortion access key factor in future US doctors' training (residency) choices, finds study

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainState access to abortion is a key factor in choosing where to apply for residency (training) programs for around three out of four futur
OB & GYN January 13,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com